Nouveau Life Pharmaceuticals Stock Price To Earnings To Growth
NOUV Stock | USD 0.0001 0.0001 50.00% |
Nouveau Life Pharmaceuticals fundamentals help investors to digest information that contributes to Nouveau Life's financial success or failures. It also enables traders to predict the movement of Nouveau Pink Sheet. The fundamental analysis module provides a way to measure Nouveau Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nouveau Life pink sheet.
Nouveau |
Nouveau Life Pharmaceuticals Company Price To Earnings To Growth Analysis
Nouveau Life's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Nouveau Life Pharmaceuticals has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Nouveau Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nouveau Life's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nouveau Life could also be used in its relative valuation, which is a method of valuing Nouveau Life by comparing valuation metrics of similar companies.Nouveau Life is currently under evaluation in price to earnings to growth category among its peers.
Nouveau Fundamentals
Return On Equity | -2.2 | |||
Return On Asset | -0.2 | |||
Current Valuation | 722.68 K | |||
Price To Earning | (0.01) X | |||
Price To Book | 22.72 X | |||
EBITDA | (163.87 K) | |||
Net Income | (357.25 K) | |||
Cash And Equivalents | 1.1 K | |||
Cash Flow From Operations | (22.91 K) | |||
Earnings Per Share | (0.02) X | |||
Beta | -4.22 | |||
Market Capitalization | 484.8 K | |||
Total Asset | 1.33 M | |||
Retained Earnings | (236 K) | |||
Working Capital | (145 K) | |||
Current Asset | 1 K | |||
Current Liabilities | 146 K | |||
Net Asset | 1.33 M |
About Nouveau Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nouveau Life Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nouveau Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nouveau Life Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nouveau Pink Sheet Analysis
When running Nouveau Life's price analysis, check to measure Nouveau Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nouveau Life is operating at the current time. Most of Nouveau Life's value examination focuses on studying past and present price action to predict the probability of Nouveau Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nouveau Life's price. Additionally, you may evaluate how the addition of Nouveau Life to your portfolios can decrease your overall portfolio volatility.